The QualityStocks Daily Monday, April 11th, 2023

Today's Top 3 Investment Newsletters

360wallstreet(PLXP) $0.3633 +245.67%

QualityStocks(GCTK) $3.2000 +168.91%

PennyStockProphet(JFBR) $1.4100 +93.68%

The QualityStocks Daily Stock List

GlucoTrack Inc. (GCTK)

We reported earlier on GlucoTrack Inc. (GCTK), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

GlucoTrack Inc. (NASDAQ: GCTK) is a medical device firm that is focused on designing, developing and commercializing glucose monitoring devices for use by individuals suffering from diabetes and pre-diabetics.

The firm has its headquarters in Or Yehuda, Israel and was incorporated in September 2001, by David Malka and Avner Gal. Prior to its name change in November 2021, the firm was known as Integrity Applications Inc. The firm serves consumers around the globe, with a focus on the Asia Pacific, the United States, Israel and Europe.

The enterprise’s products include the GlucoTrack model DF-F, a glucose monitoring device which uses a patented combination of thermal, electromagnetic and ultrasound technologies to obtain glucose readings for pre-diabetic and diabetic patients in less than a minute, through the use of a small sensor that is clipped onto the individual’s earlobe using a Personal Ear Clip. The sensor contains calibration electronics and is linked to a handheld display and control unit. The monitoring device has been designed to obtain glucose measurements without drawing interstitial fluid or blood, making the device pain-free and needle-free. The enterprise also develops a wireless module for the transmission of data of the glucose readings captured by the device to a cloud-based server.

The company recently completed its uplisting on Nasdaq, which will grow the company’s shareholder base, increase corporate visibility and allow both the company and its shareholders greater access to liquidity. This move comes after it appointed a new CEO, who has extensive experience working with new and innovative diabetes management devices.

GlucoTrack Inc. (GCTK), closed Monday's trading session at $3.2, up 168.9076%, on 78,111,051 volume. The average volume for the last 3 months is 215,472 and the stock's 52-week low/high is $0.20755/$3.75.

Avalo Therapeutics (AVTX)

QualityStocks and MarketBeat reported earlier on Avalo Therapeutics (AVTX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Avalo Therapeutics Inc. (NASDAQ: AVTX) (FRA: C6K0) is a clinical stage medicine firm that is focused on discovering, developing and commercializing therapeutics for patients with unmet clinical needs in rare genetic, immune-oncology and immunology illnesses.

The firm has its headquarters in Rockville, Maryland and was incorporated in 2011, on January 31st by Solomon H. Snyder, Barbara S. Slusher, Isaac Blech and Blake M. Paterson. Prior to its name change in August 2021, the firm was known as Cerecor Inc. It operates as part of the scientific research and development services industry and serves consumers around the world.

The company uses a precision medicine approach to develop and commercialize highly targeted therapeutics. It operates a bioassay facility in Germantown.

The enterprise’s product pipeline is made up of an anti-light mAb dubbed AVTX-002, which targets immune-inflammatory ailments like moderate-to-severe inflammatory bowel disease and acute respiratory distress syndrome. It also offers an anti-IL-18 mAb, which targets immune-inflammatory and immune-oncology illnesses like Still’s disease and multiple myeloma. Still’s disease is a disorder that’s characterized by arthritis, a rash, high spiking fevers and inflammation. In addition to this, the enterprise also develops AVTX-801, AVTX-802 and AVTX-803, which are therapeutic monosaccharide therapy doses indicated for congenital disorders of glycosylation; and a dual mTORc1/c2 inhibitor dubbed AVTX-006, which targets lymphatic malformations.

The firm is focused on addressing the significant unmet medical need for patients and advancing its programs, having recently expanded its AVTX-002 program. Meeting these needs will not only extend the firm’s consumer reach but also encourage more investments into the firm, which will be good for its growth.

Avalo Therapeutics (AVTX), closed Monday's trading session at $2.38, up 30.7692%, on 215,472 volume. The average volume for the last 3 months is 9.366M and the stock's 52-week low/high is $1.41/$8.40.

Hexo (HEXO)

InvestorPlace, Schaeffer's, MarketBeat, Kiplinger Today, Daily Trade Alert, The Wealth Report, The Online Investor, The Street, Wealth Insider Alert, StocksEarning, Trades Of The Day, Zacks, MarketClub Analysis, BUYINS.NET, StreetInsider, Profit Trends, Stock Up Featured, The Stock Dork, QualityStocks, StreetAuthority Daily, TheTradingReport, Early Bird, TradersPro, CFN Media Group and Smartmoneytrading reported earlier on Hexo (HEXO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Hexo Corp. (TSE: HEXO) (FRA: 74HA) is a marijuana firm that is engaged in the production, marketing and sale of cannabis.

The firm has its headquarters in Kanata, Canada and was incorporated in 2013, on October 29th by Adam Miron and Sébastien St. Louis. Prior to its name change in August 2018, the firm was known as Hydropothecary Corp. It operates in the global marijuana industry and serves consumers in both the medical and adult-use markets across the globe.

The company operates under the Hydropothecary brand in the medical market and under the Original Stash, Up Cannabis and Hexo Cannabis brands in the recreational markets. It has about 300,000 ft2 of production capacity and generates its revenue from international sales, wholesale sales, medical sales, recreational sales and beverage-based sales.

The enterprise is focused on traditional marijuana and smoke-free products. It provides an activated fine-milled cannabis powder product known as Decarb; a marijuana oil sublingual mist product line dubbed Elixir; Fleur de Lune intimate cannabis oil; and dried marijuana buds under the H2 and Time of Day brand names. The Time of Day product line comprises of dried cannabis for morning, midday, after dinner and bedtime while the H2 cannabis line comprises of Kush and Green Chai dried cannabis buds and Papaya Grove. It also provides marijuana beverages under the XMG, Verywell, Mollo, House of Terpenes and Little Victory brands.

The firm recently appointed a new Chief Commercial Officer, which helps expand its global leadership team and support its future growth as it continues to generate value for its shareholders, which may also increase investments into the firm.

Hexo (HEXO), closed Monday's trading session at $1.64, up 30.1587%, on 9,366,432 volume. The average volume for the last 3 months is 314,618 and the stock's 52-week low/high is $0.9006/$8.3818.

GSE Systems, Inc. (GVP)

SmarTrend Newsletters, Wall Street Resources, StockMarketWatch, StreetInsider, StockOodles, MarketBeat, PennyOmega, SmallCapVoice, Marketbeat.com, StockHotTips, BestOtc, CRWEFinance, CRWEPicks, CRWEWallStreet, PennyToBuck, DrStockPick, QualityStocks, MicroCap Gems, StreetAuthority Daily, Wealth Daily, Barchart, The Street, Zacks, Stock Spike and Timothy Sykes reported earlier on GSE Systems, Inc. (GVP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

GSE Systems, Inc. (NASDAQ: GVP) (FRA: GSE) is focused on the provision of staffing services, technical and professional engineering and simulation software to the process and power industries in various countries around the globe.

The firm has its headquarters in Columbia, Maryland and was incorporated in 1994, on March 30th. It is party to a strategic collaboration with ABB Bailey Japan Ltd which entails the provision of process simulation solutions for its Nikonkai LNG terminal in Niigata, Japan. The firm serves consumers across the globe, with a primary focus on Europe, Asia and the United States.

The company operates through the nuclear industry training and consulting, and the performance improvement solutions segments. The former segment provides project managers, technical engineers, procedure writers, planners, nuclear operations instructors, work management specialists training materials developed for the nuclear power industry. On the other hand, the latter segment is engaged in the provision of engineering services and operation training systems for the fossil fuel and nuclear power generation and process industries, as well as simulation products, which include interactive computer-based tutorials/simulations, power plant thermal performance optimization and power plant high-fidelity simulation solutions.

The enterprise markets its services and products through strategic alliance partners, representatives and agents and its network of direct sales staff. Its products are used in the metals, power generation, pharmaceutical, petroleum refining, food and beverage and specialty chemical industries.

The firm was recently awarded a contract to deliver a web-based thermal system monitoring program by a huge U.S. nuclear power plant operator. This contract will not only bring in additional revenue into the firm but may also help extend its consumer reach, which will be good for investments.

GSE Systems, Inc. (GVP), closed Monday's trading session at $0.72, up 24.7834%, on 314,716 volume. The average volume for the last 3 months is 75.669M and the stock's 52-week low/high is $0.53/$1.88.

Troika Media Group (TRKA)

QualityStocks, MarketClub Analysis, StockEarnings, StocksEarning, The Wealth Report, InvestorPlace, 360wallstreet, Broad Street, Fierce Analyst, Small Cap Firm, Mega Stock Alerts, ProTrader, Penny Stock, StockWireNews, The Stock Dork and Money Wealth Matters reported earlier on Troika Media Group (TRKA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Troika Media Group Inc. (NASDAQ: TRKA) is an advertising and marketing firm that leverages data and technology to deliver analytics, media, marketing and integrated branding solutions.

The firm has its headquarters in Los Angeles, California and was incorporated in November 2003. Prior to its name change in July 2017, the firm was known as M2 nGage Group Inc. It serves consumers in the United Kingdom and the United States.

The company’s operating units include Mission Media USA Inc., Mission-Media Holdings Ltd, Mission Culture LLC, Troika Design Group Inc. and Troika Services Inc. It provides solutions to clients seeking a holistic approach to meeting communications, experiential marketing and brand strategy needs.

The enterprise provides design, animation and post-production studio services; digital and physical experiential, crisis management, public relations, marketing strategy, brand fundamentals development services; original music and sonic branding, content creation, brand experience and fan engagement, advertising and sponsorship integration, 360 brand design, brand strategy, market research and insights, design and branding, and strategic media buying and planning services. It also provides media content for advertising opportunities, sponsorship partnerships, hospitality customers and events. The enterprise serves non-profit organizations as well as the automotive, sports, tech, telco, consumer goods, entertainment, pharmaceuticals, beverage alcohol, jewelry/watches, beauty and fashion industries.

The company recently announced its latest financial results, with its CEO noting that the firm was focused on maintaining the high quality of relationships and services with its clients, which positions them for significant growth. It is also focused on raising its margin potential and lowering its expense base.

Troika Media Group (TRKA), closed Monday's trading session at $0.2891, up 22.5%, on 78,783,668 volume. The average volume for the last 3 months is 875 and the stock's 52-week low/high is $0.095/$1.27.

Juventus Football Club (JVTSF)

MarketBeat reported earlier on Juventus Football Club (JVTSF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Juventus Football Club S.p.A. (OTC: JVTSF) (BIT: JUVE) (FRA: JUVE) (BMV: JUVEN) is a company that is focused on operating a professional football club.

The firm has its headquarters in Turin, Italy and was incorporated in 1897, on November 1st. It operates as part of the entertainment industry, under the communication services sector. The firm mainly serves consumers in Italy.

The company operates as a subsidiary of EXOR N.V. It belongs to the Italian Serie A division. The company is active mainly locally. It generates revenue from the sale of tickets, sponsorship activities, sale of advertising space, as well as licensing of television and media rights.

The enterprise’s core business is participation in national and international competitions and the organization of matches while exploiting sports events, the Juventus brand and the team image, including also the licensing of television and media rights, sponsorship, selling of advertising space, licensing and merchandising. It also markets additional services to fans and manages players' registration rights. The enterprise owns its stadium, which was inaugurated on 8 September 2011 and was named the Allianz Stadium from the 2017/18 season. In addition, it has its own modern sports center located in Vinovo, which opened in July 2006 and was designed exclusively for Juventus’ Youth and Women teams. In 2017, it transferred its registered offices to the new complex owned by the J Village Property Fund, which is situated in the vicinity of the stadium.

The firm remains committed to better meeting consumer demand and generating value for its shareholders, which will be good for its growth.

Juventus Football Club (JVTSF), closed Monday's trading session at $0.3633, up 5.3043%, on 875 volume. The average volume for the last 3 months is 171,021 and the stock's 52-week low/high is $0.26/$0.4466.

MariaDB (MRDB)

We reported earlier on MariaDB (MRDB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

MariaDB Plc (NYSE: MRDB) is a cloud database firm that is engaged in the provision of open source database and database as a service (DBaaS) solutions to support scalability, mission-critical deployments, configuring databases for production environments, and automating failover.

The firm has its headquarters in Redwood City, California and was incorporated in 2017, on June 19th. Prior to its name change, the firm was known as Mangomill Plc. It operates as part of the software-infrastructure industry, under the technology sector. The firm serves consumers around the globe, with a focus on those in the U.S. and Ireland.

The enterprise offers MariaDB Community Server, an open-source relational database; MariaDB Enterprise Server, a production-grade open-source database which delivers performance, data security, replication, clustering, and availability; MariaDB Xpand, a distributed SQL database, which combines the scalability of a NoSQL database with the robustness of a SQL database; SkySQL, a fully-managed cloud database service enabling the user to deploy and manage MariaDB Enterprise Server, Xpand distributed SQL, ColumnStore, and Serverless Analytics powered by Apache Spark SQL as database services; and MariaDB ColumnStore, an analytics and data warehousing solution, extends MariaDB Enterprise Server with distributed, columnar storage and a massively parallel processing shared nothing architecture, transforming it into a standalone or distributed data warehouse for ad hoc SQL queries and advanced analytics without the need to create indexes. It also provides technical support, consulting, and training services.

The company recently showcased its new SkySQL cloud database at the AWS Global Summit, a move that’ll help extend its reach while also bringing in additional revenues.

MariaDB (MRDB), closed Monday's trading session at $1.3, up 4.8387%, on 171,021 volume. The average volume for the last 3 months is 85,656 and the stock's 52-week low/high is $3.20/$11.55.

Aerwins Technology (AWIN)

We reported earlier on Aerwins Technology (AWIN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Aerwins Technology Inc. (NASDAQ: AWIN) is a company focused on the development and manufacture of drones and other technology in the air infrastructure and air mobility space.

The firm has its headquarters in Tokyo, Japan and was incorporated in 2017. Prior to its name change, the firm was known as Pono Capital Corp. It operates as part of the scientific and technical instruments industry, under the technology sector. The firm serves consumers around the globe.

The company mainly operates through its wholly owned subsidiary, Aerwins Inc. It is focused on enabling proper planning, monitoring, and management of aircraft condition while also ensuring safety of the surrounding environments and operators, which are the principles of automatic operation of UAVs.

The enterprise’s air mobility platform, Centralized Operating System, has been designed to help manage Open Sky (C.O.S.M.O.S.). It has also developed the XTURISMO Limited Edition Hoverbike. C.O.S.M.O.S. is a drone monitoring and management platform service. C.O.S.M.O.S. is an unmanned aerial vehicle (UAV), including drones and air mobility platform that enables proper planning, monitoring and management of aircraft condition, and ensures safety of the surrounding environments and operators. XTURISMO Limited Edition Hoverbike is a luxury air cruiser.

The company recently partnered with Outsourcing Inc. to develop and produce new air mobility products in the Middle East. This move will advance its manufacturing and production capabilities and open it up to new growth and investment opportunities while also bringing in additional revenues into the company.

Aerwins Technology (AWIN), closed Monday's trading session at $0.9, up 3.4483%, on 85,656 volume. The average volume for the last 3 months is 545 and the stock's 52-week low/high is $0.78/$18.00.

Ezagoo (EZOO)

We reported earlier on Ezagoo (EZOO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Ezagoo Limited (OTC: EZOO) is a company mainly engaged in providing digital advertising services to consumers.

The firm has its headquarters in Beijing, China and was incorporated in 2018, on May 9th. It is also known as Hunan Ezagoo Zhicheng Internet Technology Ltd. The company operates as part of the advertising agencies industry, under the communication services sector. The firm mainly serves consumers in the People’s Republic of China.

The company’s primary business activity is to display advertisements for its clients on television screens mounted on public buses that move throughout Changsha City. It conducts its businesses mainly in the domestic market.

The enterprise operates within the Chinese digital advertising network through advertisements displayed on flat-panel audiovisual television displays. It offers display advertisement services on TV screens mounted on public buses and the mobile application named Xindian that operates over the internet. The enterprise focuses on telecommunication, e-commerce, and electronics products for sales.

The firm is focused on growing its business rapidly, given its status as an emerging growth company. It relies heavily on information technology, or IT, systems to manage critical functions such as advertising campaign management and operations, data storage and retrieval, revenue recognition, budgeting, forecasting, financial reporting and other administrative functions. To manage its growth effectively, the firm is committed to improving and expanding its infrastructure, including their IT, financial and administrative systems and controls. This will help create value for its shareholders while also opening it up to new investment opportunities.

Ezagoo (EZOO), closed Monday's trading session at $1.03, up 0.49761%, on 545 volume. The average volume for the last 3 months is 7 and the stock's 52-week low/high is $0.0341/$1.30.

Real Matters (RLLMF)

StreetInsider and MarketBeat reported earlier on Real Matters (RLLMF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Real Matters Inc. (OTC: RLLMF) (TSE: REAL) (FRA: R3E) is a company engaged in the provision of technology and network management solutions to mortgage lending and insurance industries.

The firm has its headquarters in Markham, Canada and was incorporated in 2004 by Michael A. Johnston. Prior to its name change in July 2010, the firm was known as Solidifi Inc. It operates as part of the software-application industry, under the technology sector. The firm serves consumers in Canada and the United States.

The company operates through the following segments: United States Appraisal, United States Title, and Canada. The United States Appraisal segment offers residential mortgage appraisals for purchase, refinance, home equity, and default transactions through its Solidifi brand. The United States Title segment serves the title market by providing various title services for refinance, purchase, short sale, and real estate owned transactions to financial institutions through its Solidifi brand. The Canada segment includes residential mortgage appraisals for purchase, refinance, and home equity transactions provided through its Solidifi brand. The company generates maximum revenue from the U.S. Appraisal segment.

The enterprise also offers insurance inspection services to property and casualty insurers across Canada through its iv3 brand. It serves real estate appraisers, lenders, mortgage insurers, and originators in the North American financial services industry.

The firm, which is set to announce its latest financial results, remains focused on increasing its share of the market and increasing its revenues. This will positively influence shareholder value as well as boost the firm’s overall growth.

Real Matters (RLLMF), closed Monday's trading session at $3.4, even for the day. The average volume for the last 3 months is 3.25M and the stock's 52-week low/high is $3.02/$4.74.

Workhorse Group Inc. (WKHS)

Green Car Stocks, InvestorPlace, MarketClub Analysis, Schaeffer's, QualityStocks, Kiplinger Today, MarketBeat, StockMarketWatch, StocksEarning, TradersPro, StreetInsider, Early Bird, The Street, Trades Of The Day, Daily Trade Alert, The Online Investor, TraderPower, TopPennyStockMovers, Zacks, BUYINS.NET, Wealth Insider Alert, Cabot Wealth, InvestorsUnderground, Jason Bond, Marketbeat.com, PoliticsAndMyPortfolio, StockEarnings, StockOodles, Stock Beast, Wealth Daily, Energy and Capital, The Best Newsletters, Daily Market Beat, The Wealth Report and Profitable Trader Authority reported earlier on Workhorse Group Inc. (WKHS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Beginning this month, the American Department of Treasury will tighten requirements for customers to qualify for a substantial income tax break when they purchase new EVs, mandating that critical components, particularly materials for batteries, be primarily sourced from North America. The tax credit of not less than $7,500 offered to consumers who buy new electric vehicles was made possible by the Inflation Reduction Act, which was passed into law in 2022. However, due to the stricter new regulations on the source of battery materials and components set to be imposed on April 18, 2023, several electric vehicles are expected to miss out on this tax credit from the government.

The added adjustments have added some complexity to the auto industry. Given that electric vehicles spearheaded by Tesla have witnessed record-breaking sales in the United States and accounted for approximately 6% of total car sales in 2022, the Auto Alliance claims the industry accounted for 10% of the vehicle market in December last year, and due to the accessibility of the tax credits, it most likely expanded more in the first quarter of 2023.

According to John Bozzella in a blog post, it is still unclear which electric vehicles are currently eligible for the federal credit under the new rules and which are not. Bozzella said that the most recent development will definitely reduce the pool of electric vehicles that qualify. In the foreseeable future, fewer automobiles will be eligible for the entire $7,500 tax credit.

Until now, vehicle manufacturers have been unable to persuade the U.S. government to relax the new standards, considering that the United States, Mexico and Canada currently produce only a small number of the necessary components and raw resources needed in batteries. The IRA deliberately inserted that rule to encourage a completely new local supplier base. General Motors, Ford and several other companies, including start-ups such as Redwood Materials and Sila, intend to start manufacturing anodes and cathodes for batteries domestically.

But it is likely to require up to three years before there is a greater supply of these materials, which are currently mainly imported through China.

According to Jessica Caldwell, plans to manufacture or source battery materials should not be made hastily. While vehicle producers are probably appreciative of the government’s push regarding an inexpensive transition to EVs, adherence to the new regulations could be marred by discontent and some scrambling behind closed doors.

The announcement did not offer much new information as to which electric vehicles are eligible for the tax benefit under the new regulations. Prospective buyers of models from various startups such as Workhorse Group Inc. (NASDAQ: WKHS) may need to talk to their suppliers in order to be helped to understand which applicable tax breaks they may qualify for.

Workhorse Group Inc. (WKHS), closed Monday's trading session at $1.11, off by 0.44843%, on 3,250,411 volume. The average volume for the last 3 months is 7.94M and the stock's 52-week low/high is $1.08/$4.73.

Hecla Mining Company (HL)

MarketClub Analysis, SmarTrend Newsletters, Schaeffer's, InvestorPlace, Wyatt Investment Research, StocksEarning, Lebed.biz, MarketBeat, QualityStocks, Top Pros' Top Picks, TopStockAnalysts, StreetAuthority Daily, INO.com Market Report, The Street, Money Morning, Zacks, Jason Bond, Marketbeat.com, Kiplinger Today, Daily Trade Alert, Today's Financial News, Wall Street Grand, StreetInsider, Trades Of The Day, INO Market Report, TheStockAdvisors, TradersPro, Streetwise Reports, StockOodles, Gryphon Digest, The Wealth Report, StockEarnings, Penny Detectives, TradingAuthority Daily, National Inflation Association, SureMoney, Stockhouse, TraderPower, Options Elite, Wall Street Daily, DividendStocks, ChartAdvisor, Penny Sleuth, PennyStockLive, The Growth Stock Wire, Profit Confidential, ProfitableTrading, Darwin Investing Network, Barchart, Investing Lab, Investing Futures, CRWEFinance, BestOtc, CRWEPicks, CRWEWallStreet, Greenbackers, Daily Markets, Daily Wealth, Forbes, DrStockPick, CustomerService, Rockwell Trading, Weiss Research, WealthMakers, Wealth Insider Alert, TradingMarkets, Traders For Cash Flow, Trade of the Week, The Online Investor, StockHotTips, PennyOmega, SmallCapVoice, Investopedia, Residual Income Report, PennyToBuck, AllPennyStocks, MonsterStocksPicks, Money and Markets, MarketArmor.com, InvestorGuide, Investor Update, Investor Guide and Stock Stars reported earlier on Hecla Mining Company (HL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Around 10% of the world’s land, or 5.8 million square miles, is covered in glacial ice. Most of these glaciers were formed in the last ice age, with the largest ones forming in Antarctica, followed by Alaska. However, years of unprecedented global warming have caused glaciers to start melting at a faster-than-usual rate.

Experts estimate that if global warming continues at current rates, the world will lose a whopping 68% of its ice glaciers by the year 2100. In the meantime, melting glaciers are uncovering terrain hidden for thousands of years, revealing ancient artifacts, mineral deposits and even potentially dangerous microbes.

Although countries worldwide are working to reduce their carbon emissions, the damage is already done. The planet is heating up, and the Arctic is taking the brunt of it, heating up nearly four times faster than the rest of the globe for nearly half a century.

On average, the Arctic is now 3℃ warmer than it was in 1980. This relatively “small” temperature increase has disrupted the region’s delicate balance and is poised to have worldwide repercussions. The world has already lost around 276 billion tons’ worth of glaciers a year from 2000 to 2019.

Columbia Climate School’s Lamont-Doherty Earth Observatory climate geologist and Greenland ice sheet researcher Joerg Schaefer said his research indicates that melting ice will reveal the underlying bedrock much faster than expected. He said that all predictions on how fast glaciers will melt are “too conservative,” noting that predictions for Greenland are especially conservative due to various climate factors.

As this ice melts and the bedrock underneath is revealed, new mining and fuel extraction opportunities may emerge. Estimates from the United States Geological Survey show that around 13% of the globe’s undiscovered oil and 30% of undiscovered gas may be offshore in the North Arctic Circle. Furthermore, the U.S. Congressional Research Services estimates that there is $1 trillion worth of minerals and precious metals in the Arctic.

The deep Arctic seabed also contains rare earth metal, nickel and copper deposits, and Norway has already begun exploring its sea floor to extract zinc, copper, silver, cobalt and gold. Prospectors will likely begin to move in as the land becomes more accessible to discover gold, copper, cobalt, coal, rare earth metals and copper deposits.

However, there are concerns that deep-sea mining could cause significant damage to marine ecosystems. Some companies and environmental groups have called for a temporary prohibition of deep sea mining until we fully understand the environmental risks of extracting minerals from the deep sea bed.

These new deposits brought to the surface as glaciers melt offer extraction companies such as Hecla Mining Company (NYSE: HL) new opportunities to leverage as they meet the growing demand for different minerals around the world.

Hecla Mining Company (HL), closed Monday's trading session at $6.41, even for the day, on 8,627,442 volume. The average volume for the last 3 months is 19,728 and the stock's 52-week low/high is $3.41/$7.3801.

The QualityStocks Company Corner

Silo Pharma Inc. (OTCQB: SILO)

The QualityStocks Daily Newsletter would like to spotlight Silo Pharma Inc. (OTCQB: SILO).

Silo Wellness Inc. (CSE: SILO) (OTCQB: SILFF) (FSE: 3K7A), is pleased to advise thattrading of its common shares on the CSE will resume (Tuesday, April11, 2023). As previously announced, the cease trade order was revoked by the Ontario SecuritiesCommission, and all outstanding annual filing documents have beenfiled by the Company.

Shareholder Updates

Please follow Silo Wellness and help share news: newslettersubscription at SiloWellness.com; Twitter ($SILFF); LinkedIn; Facebook; and Instagram. Investor Relations: 902-818-8807.

Silo Pharma Inc. (OTCQB: SILO), a developmental stage biopharmaceutical company, is focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as post-traumatic stress disorder (PTSD), fibromyalgia, Alzheimer’s disease, Parkinson’s disease, and other rare neurological disorders. Silo’s mission is to identify assets to license and fund research that the company believes will be transformative to the wellbeing of patients and the health care industry.

Silo is committed to developing innovative solutions to address a variety of underserved conditions. Combining Silo’s resources with world-class medical research partners, the company looks to make significant advances in the medical and psychedelic space.

Silo works to identify and partner with leading medical universities, providing the needed financial resources to develop safe therapeutic treatments while moving cutting-edge research through the clinical stage and into commercialization. The company is well-capitalized with access to additional funds as opportunities present themselves.

Silo recently engaged Donohoe Advisory Associates LLC for consulting and advisory services in connection with the potential uplisting of Silo’s common shares to the Nasdaq Stock Market.

Research

Silo has entered into research agreements and partnerships with multiple leading medical universities.

The company is involved in a sponsored study with Maastricht University utilizing repeated low doses of ketamine and psilocybin to examine the effects on cognitive and emotional dysfunctions in Parkinson’s disease and to understand its mechanism of action. The investigator in the Netherlands is acquiring the substances for the study and will then finalize the documentation to submit to the ethics committee.

Additionally, in June 2021, Silo announced its entry into a scientific research agreement with the University of California San Francisco (UCSF). The agreement will leverage four other clinical trials being planned by the university to determine the effects of psilocybin on inflammation. The study will take place at The Translational Psychedelic Research (TrPR) Program at UCSF.

Silo also recently extended its exclusive option agreement with the University of Maryland, Baltimore (UMB) to explore a novel invention generally known as joint-homing peptides. These peptides are being developed for use in the investigation and treatment of arthritogenic processes and can be used for enhanced targeting of therapeutic agents.

This agreement includes the study of two separate peptides. The first is an option and study for the treatment of arthritis. The second is a patented licensed peptide for the central nervous system, with an initial study for MS autoimmune diseases, in addition to rheumatoid arthritis. Animal studies are underway for both initial indications relating to the UMB agreement, with the potential for studies evaluating additional indications in the future.

Finally, Silo signed an agreement with Columbia University granting it an option to license certain assets currently under development, including an Alzheimer’s disease formulation targeting NDMARs and 5-HT4Rs, as well as a prophylactic treatment for stress-induced disorders and PTSD. Both candidates are currently being tested in mice and have already provided early data.

In addition to its university partnerships, Silo entered a joint venture agreement with Zylo Therapeutics Inc. (“ZTI”) focused on the development of ketamine and psilocybin using ZTI’s Z-Pod™ technology for the transdermal time released delivery of therapeutics. In November 2021, the company announced ZTI’s reception of its first ketamine shipment and initiation of loading ketamine into its Z-Pod technology. In a news release, Eric Weisblum, CEO of Silo, called the development an “important milestone” that will help the company “study the benefits of slow-release transdermal release of Ketamine.”

Market Overview

According to Coherent Market Insights, the fibromyalgia treatment market was valued at $2.78 billion in 2018 and has a projected CAGR of 3.3% over the forecast period 2018 to 2026. Fibromyalgia is a condition that causes pain all over the body, sleep problems, fatigue, and emotional and mental distress.

The global PTSD therapeutics market is expected to reach $10.68 billion by 2026 with a CAGR of 4.5% during the forecast period from 2018 to 2026, according to a report by Credence Research. Growing prevalence of PTSD is the chief factor driving the global treatment market. Increases in events such as wars, combat, and interpersonal violence has been a major contributing factor. Other factors like growing emphasis on rehabilitation initiatives by governments for treating their war veterans has also been facilitating the increase in demand for PTSD therapeutics.

Fortune Business Insights reports the global Parkinson’s disease treatment market is predicted to grow to $8.38 billion by 2026, with a CAGR of 8.1% during the forecast period. Parkinson’s is a neurodegenerative disease of the central nervous system which primarily affects the brain, causing uncontrollable shaking and tremors, difficulties in balance and restricted body movement making it difficult for the person to function or perform a daily routine.

Management Team

Eric Weisblum is CEO and founder of Silo Pharma. He has over 25 years of Wall Street experience, most recently in the biotechnology sector. He has served on the board of Aikido Pharma and was the president of Sableridge Capital. He has a proven track record in licensing therapeutic assets and assisting in their development. He brings to the company nearly 20 years of expertise in structuring and trading financial instruments. He holds a bachelor’s degree from the University of Hartford’s Barney School of Business.

Dr. Kevin Muñoz was appointed to the Silo board of directors in October 2020. He teaches biomedical sciences and medical intervention for the Passaic County Technical Institute. He previously served as Director of Operations at Physical Medicine and Rehabilitation. He began his career with Harlem Health Promotion Center in New York City as a research assistant. He earned a bachelor’s degree from the University of Michigan and a Doctor of Medicine from Xavier University School of Medicine.

Josh Woolley, M.D., Ph.D., is a Scientific Advisor for Silo. He is an associate professor in the Department of Psychiatry and Behavioral Sciences at the University of California, San Francisco. He is also a psychiatrist on staff at the San Francisco Veterans Affairs Medical Center. He is the director and founder of the Bonding and Attunement in Neuropsychiatric Disorders Laboratory. He received both his M.D. and his Ph.D. in Neuroscience from UCSF, where he completed his psychiatry residency training.

Charles Nemeroff, M.D., Ph.D., is a Scientific Advisor for Silo Pharma. He directs the Institute for Early Life Adversity Research within the Department of Psychiatry and Behavioral Sciences as part of the Mulva Clinic for the Neurosciences. He was chair of the Department of Psychiatry and Behavioral Sciences and clinical director of the Center on Aging at the University of Miami Miller School of Medicine. He received his M.D. and Ph.D. in neurobiology from the University of North Carolina School of Medicine.

Silo Pharma Inc. (OTCQB: SILO), closed Monday's trading session at $2.39, up 1.7021%, on 19,728 volume. The average volume for the last 3 months is 1.078M and the stock's 52-week low/high is $1.71/$12.25.

Recent News

D-Wave Quantum Inc. (NYSE: QBTS)

The QualityStocks Daily Newsletter would like to spotlight D-Wave Quantum Inc. (NYSE: QBTS).

D-Wave has worked on quantum hybrid applications with commercialcustomers including industry leaders like Volkswagen, Mastercard,Deloitte, ArcelorMittal, Siemens Healthineers, Unisys, Accenture,BBVA, NEC Corporation, Pattison Food Group Ltd., DENSO, andLockheed Martin

The company’s intellectual property portfolio includes more than210 issued US patents and more than 100 peer-reviewed papers inleading scientific journals

D-Wave’s customer success stories showcase the company’s quantumcomputing technology in action

D-Wave Quantum (NYSE: QBTS), a leader in quantum computing systems, software and services,focused on delivering value to customers via practical quantumapplications for problems such as logistics, artificialintelligence, materials sciences, drug discovery, scheduling, faultdetection, and financial modeling, showcases the tangible value ofits practical quantum computing solutions through its customersuccess stories.

D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow.

D-Wave is a pioneer in quantum computing, with a history of delivering the world’s first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service) and Ocean™ (full suite of open-source programming tools).

D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 use D-Wave.

D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO and Lockheed Martin. The company boasts an extensive IP portfolio featuring more than 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals.

Founded in 1999, D-Wave is the world’s first commercial supplier of quantum computers. With headquarters and the Quantum Engineering Center of Excellence based near Vancouver, Canada, D-Wave’s U.S. operations are based in Palo Alto, California.

Advantage™ Quantum Computer

 

With the Advantage™ Quantum Computer, D-Wave has incorporated two decades of experience and over 10 years of customer feedback to create the first and only quantum computer designed for business. The platform features a new processor architecture with over 5,000 qubits and 15-way qubit connectivity. This is 2.5x more connections and more than double the number of qubits than the company’s previous generation quantum computer.

D-Wave’s quantum computers, first located in its facilities in British Columbia, have been available to North American users through its Leap™ quantum cloud service since 2018. It has since introduced new Advantage systems in Julich, Germany, and most recently, Marina Del Rey, California, which marked the availability of the first Advantage quantum computer physically located in the United States.

That new deployment is part of the USC-Lockheed Martin Quantum Computing Center (QCC) hosted at USC’s Information Sciences Institute (ISI), a unit of the University of Southern California’s prestigious Viterbi School of Engineering. Additionally, Amazon Web Services (AWS) and D-Wave announced that the U.S.-based system is available for use in Amazon 2racket, expanding the number to three different D-Wave quantum systems available to AWS users.

Leap Quantum Cloud Service

 

D-Wave’s customers interface with its systems through the Leap™ quantum cloud service. Leap delivers immediate, real-time access to the company’s Advantage quantum computer and quantum hybrid solver service, all with enterprise-class performance and scalability.

Leap allows developers proficient in Python to get started building and running quantum applications. Through a seamless and secure cloud-based connection, users can easily start solving complex problems of up to 1 million variables and 100,000 constraints.

Using Leap, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail and transportation. By eliminating the need to wait hours, days or weeks to get good answers to a broad array of problems, D-Wave is helping businesses move forward.

D-Wave Launch

D-Wave Launch™ is the company’s onboarding platform aimed at helping businesses easily start their quantum journey. Through this program, D-Wave’s team of experts and partners aid enterprises in identifying best use cases for quantum and work with them to develop a proof of concept and production pilot.

From there, the team coordinates with customers to get their hybrid quantum applications up and running, providing ongoing Leap quantum cloud access to ensure the application is operating smoothly and delivering real business value.

Target Verticals

While the potential applications for quantum computing are effectively limitless, D-Wave has identified a number of industry verticals as key areas of focus for its quantum architecture, providing case studies for each. These include:

  • Manufacturing – D-Wave worked with Volkswagen to identify a commercial optimization application, the binary paint shop problem, which was run on D-Wave’s hybrid solver service. The solver outperformed four purely classical methods on problem sizes at commercial scale (N=3,000). In a separate project, similar inputs were tested using a leading ion trap system, which failed to find any commercial solution.
  • Life Sciences – Menten AI makes use of D-Wave quantum computing to assist in the design of novel therapeutic peptides—short strings of amino acids that can act as potent drugs. With the rise of COVID-19, D-Wave’s Advantage system made it possible to identify molecules that might be especially well-suited for binding and inhibiting the related spike protein, producing several promising peptide designs.
  • Finance – Multiverse Computing, a leader in developing quantum solutions for the financial sector, leveraged D-Wave’s hybrid solver service in a collaboration with BBVA, one of the world’s largest financial institutions. Multiverse demonstrated management strategies that far exceeded the granularity of traditional returns in a fraction of the time, helping BBVA identify a low-risk portfolio for investment.

Market Opportunity

The quantum computing total addressable market is projected to grow between $450 billion and $850 billion over the next 15 to 30 years, with between $5 billion and $10 billion of anticipated TAM growth coming in the next three to five years, according to Boston Consulting Group. Driving factors behind this growth include rising investments in quantum computing tech by governments and an increasing number of commercial use-cases.

Forward-thinking organizations see quantum as an opportunity to move ahead of the competition. From finding efficiencies and reducing waste to decreasing time to solution and solving problems abandoned due to complexity, the business value is real. According to data from 451 Research, 40% of large enterprises are already experimenting with quantum computing.

D-Wave is strategically positioned – in an industry with significant barriers to entry – as evident by a decades-long track record serving a roster of blue-chip customers. The company is singularly focused on helping its customers achieve clear value by leveraging quantum computing in practical business applications. With a full stack of systems, software, developer tools and services, D-Wave is working to enable enterprises, governments, developers and researchers to access the power of quantum computing, thereby providing an intriguing opportunity for prospective investors.

D-Wave’s current investor base includes PSP Investments, Goldman Sachs, BDC Capital, NEC Corporation, Aegis Group Partners and In-Q-Tel.

Leadership Team

Dr. Alan Baratz has served as the CEO of D-Wave since 2020. Previously, as Executive Vice President of R&D and Chief Product Officer, he drove the development, delivery, and support of all of D-Wave’s products, technologies, and applications. Dr. Baratz has over 25 years of experience in product development and bringing new products to market at leading technology companies and software startups. As the first president of JavaSoft at Sun Microsystems, he oversaw the growth and adoption of the Java platform from its infancy to a robust platform supporting mission-critical applications in nearly 80 percent of Fortune 1000 companies. He has also held executive positions at Symphony, Avaya, Cisco, and IBM. Dr. Baratz holds a doctorate in computer science from the Massachusetts Institute of Technology.

John Markovich is the company’s CFO. He brings to D-Wave over three decades of experience working with rapidly growing private and public technology companies across all stages of development. Mr. Markovich has directed the finance, accounting, tax, treasury, M&A, legal, operations, customer service, IR, HR, and IT functions for companies ranging from privately held pre-revenue startups to an NYSE-listed Fortune 500 multi-national company with over $1.2 billion in annual revenue. During his career, he has negotiated and closed over 150 debt, equity, M&A, and joint venture transactions exceeding $2.5 billion in value; over a dozen private placements; nearly a dozen M&A transactions; and several international joint ventures. Mr. Markovich holds a BS in Business from Miami University and an MBA from the Michigan State Graduate School of Business.

D-Wave Quantum Inc. (NYSE: QBTS), closed Monday's trading session at $0.8501, up 10.4026%, on 1,093,450 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $12.25/$.

Recent News

Jupiter Wellness Inc. (NASDAQ: JUPW)

The QualityStocks Daily Newsletter would like to spotlight Jupiter Wellness Inc. (NASDAQ: JUPW).

The American Pregnancy Association estimates that an estimated 40%–50% of women experience some degree of postpartum hair loss. This condition ischaracterized by hair shedding after childbirth, typically three months after giving birth. A person withpostpartum hair loss loses an average of 300 hairs per day comparedto typical hair loss, which is around 50–100 hairs daily. Such significant hair loss often becomes apparent during brushingor washing hair; it can even cause thinning and bald patches insome women. The hair loss usually takes six months on average toresolve, but it can sometimes persist for up to a year after childbirth. If the hair loss doesn’t resolve within six months, you shouldconsider seeing a physician to ensure the hair loss isn’t due to anunderlying reason. For individuals who qualify, products fromenterprises such as Jupiter Wellness Inc. (NASDAQ: JUPW) can help to stem the tide of hair loss and help women regrow theirhair.

Jupiter Wellness Inc. (NASDAQ: JUPW) is a diversified company that supports health and wellness by researching and developing over-the-counter (OTC) products and intellectual property. The company has a robust and growing portfolio of granted and pending patents to protect its proprietary products.

Jupiter Wellness’s product pipeline, backed by clinical research to ensure efficacy, addresses a range of underserved conditions. The company’s revenue is generated through a combination of OTC and consumer product sales, contract research agreements, and licensing royalties.

Jupiter Wellness was formed in 2018 and is headquartered in Jupiter, Florida.

Products with Purpose

Jupiter Wellness’s product pipeline currently targets a variety of indications with underserved needs. These include:

  • Hair Loss – Jupiter Wellness’s Minoxidil Booster is a topical treatment that’s been clinically shown to increase the enzymes needed for minoxidil to work by up to 7x over a two-week period. The product has been licensed to Taisho, a $2.6 billion revenue company and Japan’s leading seller of minoxidil products, which expects to launch it commercially in 2023. The product is licensed to India-based Cosmofix Technovation Pvt. Ltd. and Sanpellegrino Cosmetics, and additional licensing opportunities are being pursued.
  • Psoriasis & VitiligoPhotocil safely and effectively permits phototherapy treatments at home by blocking harmful radiation and permitting the passage of therapeutic UV radiation. The product has been licensed abroad and is currently being launched commercially in India by Eris Oaknet Healthcare and Cosmofix Technovation under the brand name PhotoFirst. The product is also available in the U.S., and the company is working to find new partners in dermatology for expanded distribution.
  • Jellyfish Protection SunscreenNoStingz is a topical protection from jellyfish, sea lice, and UVA/UVB rays. It provides an effective barrier against the stinging mechanism of jellyfish cnidocytes, preventing the delivery of venom to the victim. NoStingz is currently available online through Amazon and Walmart, as well as in select stores.
  • EczemaJW-100 is a pre-revenue topical treatment for atopic dermatitis (eczema). In prior studies, JW-100 cleared or reduced eczema symptoms following 2 weeks of use. Results suggest that JW-100 may potentially prove superior to existing prescription drugs. It is currently being evaluated in a Phase 3, double-blind, placebo-controlled multicenter trial.
  • BurnsJW-300 is a pre-revenue topical treatment for first-degree burns and sun exposure. In prior studies, JW-300 was shown to significantly lower the incidence of burns in patients exposed to UV radiation. It is currently being evaluated for sale as an “after sun” consumer product.
  • Cold SoresJW-400 is a pre-revenue topical treatment of herpes labialis (cold sores). A phase 1, double-blind, placebo-controlled investigational study is currently being planned for JW-400.
  • Sexual WellnessJW-500 is a pre-revenue topical treatment for female libido loss. In clinical studies, the topical formulation improved nipple sensitivity and alleviated associated sexual problems. Jupiter Wellness plans to file for a pre-IND meeting with the U.S. FDA within the next 12 months and intends to seek Orphan Drug Designation.
  • COVID-19-Induced TinnitusJW-600 is currently being evaluated in a triple-blind clinical study. Up to 15% of patients recovering from COVID-19 have experienced post-acute COVID-19-induced tinnitus

Management Team

Brian John is the CEO of Jupiter Wellness. For the past 20 years, he has been an investor and advisor to companies around the globe. He is the founder of a successful financial consulting firm specializing in helping emerging growth companies and has worked with hundreds of companies in dozens of countries over the last 25 years. Mr. John also serves on the board of directors of The Learning Center at the Els Center of Excellence – a school for children with autism in Jupiter, Florida.

Doug McKinnon is the CFO of Jupiter Wellness. His 35+ year professional career includes financial, advisory, and operational experience across a broad spectrum of industry sectors, including oil and gas, technology, cannabis, and communications. He has served in C-Level positions in both private and public sectors, including as chairman and CEO of an American-stock-exchange-traded company; as VP – Chief Administrative Officer of a $12-billion-market-cap Nasdaq-traded company; as CFO of several publicly-held U.S., Canadian and Australian companies; and as CEO/CFO of various other private enterprises.

Dr. Glynn Wilson is the Chief Scientific Officer of Jupiter Wellness. He brings to the company an extensive background of success in corporate management and product development with tenures in both multinational and start-up biotech organizations. He was formerly Head of Drug Delivery at SmithKline Beecham Pharmaceuticals; Research Area Head in Advanced Drug Delivery at Ciba-Geigy Pharmaceuticals; and Founder, CEO, and Chairman of TapImmune Inc., which became Marker Therapeutics through a merger. At TapImmune, he licensed cancer vaccine technology platforms and established the clinical pipeline.

Jupiter Wellness Inc. (NASDAQ: JUPW), closed Monday's trading session at $2.05, up 3.0151%, on 73,251 volume with 375 trades. The average volume for the last 3 months is 57,207 and the stock's 52-week low/high is $1.04999995/$5.63000011.

Recent News

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF)

The QualityStocks Daily Newsletter would like to spotlight EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF).

EverGen (TSX.V: EVGN) (OTCQX: EVGIF) is a leading Canadian renewable energy company and Canada’srenewable natural gas (“RNG”) infrastructure platform. The companyis focused on achieving a net-zero future by leveraging the powerof RNG, a carbon-neutral alternative to natural gas that iscompatible with existing pipeline infrastructure. “EverGen leadsRNG adoption in Canada by acquiring, developing and managing aportfolio of RNG and waste-to-energy products while planning todevelop an RNG platform of 20+ facilities within five years. Thecompany currently owns and operates five RNG and/or organicprocessing facilities across Canada. These include Fraser ValleyBiogas, Sea to Sky Soils, and Net Zero Waste Abbotsford in BritishColumbia, a 67% ownership stake in GrowTEC in Alberta, and a 50%stake in Project Radius located in Ontario. RNG generated fromseveral of these projects, including Fraser Valley Biogas, Net ZeroWaste Abbotsford, and GrowTEC, is bought by FortisBC through along-term offtake agreement,” a recent article reads. “Canada isnot alone in its push for RNG adoption. The United States andeighteen European Union nations are investing in RNG projects in aneffort to reduce emissions and promote sustainability. Further,several North American gas utilities have established targets toincorporate RNG into their natural gas supplies that range from5-15%. EverGen’s management recognizes this transition as apotential opportunity worth over C$16 billion for RNG producers.”

To view the full article, visit https://ibn.fm/PFOIq

EverGen Infrastructure Corp. (TSX.V: EVGN) (OTCQX: EVGIF) is developing Canada’s Renewable Natural Gas Infrastructure Platform, starting on the west coast in British Columbia. The company is combating climate change and helping communities contribute to a sustainable future by acquiring, developing, building, owning and operating a portfolio of renewable natural gas (RNG), waste-to-energy, and related infrastructure projects.

While EverGen is currently focused on British Columbia, its continued growth is expected across other regions of North America. RNG is produced differently than conventional natural gas, without drilling wells. RNG is derived from biogas, which is captured from decomposing organic waste in landfills, food waste, agricultural waste matter and wastewater from treatment facilities. This waste feedstock is supplied to an anaerobic digester which contains bacteria that breaks down organic matter in the absence of oxygen. The resulting biogas is captured and cleaned to create carbon neutral or carbon negative RNG to be used by the existing North American gas pipeline grid. By capturing these emissions and transforming them into RNG, then combusting into CO2, the overall greenhouse gases (GHG) impact is materially less potent than allowing natural decomposition to release methane into the atmosphere. Liquid and solid digestate matter is a byproduct of the RNG production process and is used as fertilizer and in other applications.

EverGen operates three projects in British Columbia. The company was incorporated in 2020 and went public in 2021, with its common shares listed on the TSX Venture Exchange under ticker symbol ‘EVGN’. In February 2022, EverGen’s common shares began trading on the OTCQB Venture Market in the U.S. under ticker symbol ‘EVGIF’. The company is headquartered in Vancouver.

Portfolio Projects

Fraser Valley Biogas is one of three projects in EverGen’s portfolio. Located in Abbotsford, British Columbia, the facility has been digesting manure and off-farm organics since 2011 and was the first agricultural digester in Canada to produce RNG. The RNG generated through this project is part of a FortisBC program to supply renewable gas to homes, businesses and other customers. Fraser Valley Biogas also provides Abbotsford farms with renewable fertilizer via the digestate produced. EverGen acquired Fraser Valley Biogas early in 2021 and is currently enhancing and expanding the facility. These optimization projects resulted in record production during the month of September 2021, supporting the growing demand for RNG in British Columbia. Optimization activities contributed an additional 18% of RNG production for September and a 9% higher year-to-date production compared to the previous year. The facility produces approximately 80,000 gigajoules of RNG, enough to heat more than 1,000 homes for a year.

Net Zero Waste Abbotsford, a wholly owned EverGen subsidiary and portfolio project, is an existing composting and organic processing facility and RNG expansion project. The British Columbia Utilities Commission recently approved a 20-year offtake agreement between the facility and FortisBC, an electricity and gas utility. Under this agreement, FortisBC will purchase up to 173,000 gigajoules of RNG annually for injection into its natural gas system upon completion of an anaerobic digester project at Net Zero Waste Abbotsford. Once construction is complete, this project is expected to produce enough energy to meet the needs of more than 1,900 homes.

Sea to Sky Soils, a wholly owned EverGen subsidiary and portfolio project, is an existing composting and organic processing facility and potential future RNG expansion project which has been operating near Pemberton, British Columbia, on Lil’wat Nation land since 2012. The Lil’wat Nation is a key partner and supporter of the facility, which has employed a majority of its staff from the First Nation since inception. The Sea to Sky Soils facility processed approximately 160 percent of its forecast tonnage in the second half of 2021. In total, Sea to Sky Soils processed approximately 36,000 tons of organic waste in 2021. The facility is working with the Ministry of Environment to expand its operational capacity in 2022. EverGen has partnered with local municipalities – including Metro Vancouver and the municipality of Pemberton – for the delivery of additional organic waste to the facility. The facility is an important part of EverGen’s RNG infrastructure platform and serves as a source of valuable feedstock to support the company’s existing and future operations.

Market Outlook

A report from Global Market Insights states that the biogas market is projected to see significant growth over the next few years, driven by a shifting preference to utilize biogas to reduce emission levels from traditional fuels. Escalating RNG usage by gas utilities as a sustainable and low carbon alternative to supply heat and electricity in industries and buildings will further stimulate growth. RNG is increasingly deployed across the transport sector, especially for heavy vehicles and vessels, to abate GHG emissions.

Many North American gas utilities have set RNG targets of 5% to 15% of production by volume in 2030, compared to less than 1% by volume in 2020. FortisBC has a goal of including 15% RNG in its gas supply by 2030. EverGen believes this presents a potential C$16 billion+ opportunity for RNG producers.

Management Team

Chase Edgelow is co-founder and CEO at EverGen. He has over 15 years of specialized private investment, finance, and technical expertise in the energy and infrastructure sectors. His background is as a Facilities Engineer with Petro-Canada, independently managing energy infrastructure capital projects located in western Canada. He holds a Professional Engineer designation from the province of Alberta.

Mischa Zajtmann is co-founder and President at Evergen. He has 15 years of experience providing consulting and management for Canadian and American companies in the natural resources and energy space. He is a corporate securities lawyer who began his career at Blake, Cassels & Graydon LLP. His J.D. is from the University of Saskatchewan Law School. He’s a member of the British Columbia Bar.

Sean Mezei is COO at EverGen. He has 20 years of experience in the RNG industry, having served previously as the president of Greenlane Biogas and as a senior manager at QuestAir, and founder and president of Dekany Consulting. He was a co-chairman of the American Biogas Council’s RNG working group for six years. He has been a Registered Professional Engineer in the province of British Columbia since 1994.

Natasha Monk is CFO at EverGen. She is a CPA with 12 years accounting, financial reporting, and tax experience in public practice and industry. She is currently a partner at Affirm LLP, where she advises and consults to a wide variety of companies in multiple industries across public and private sectors. Prior to joining EverGen, she worked at KPMG. She graduated from the University of Calgary.

EverGen Infrastructure Corp. (OTCQX: EVGIF), closed Monday's trading session at $2.59, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $1.365/$3.20.

Recent News

Advanced Container Technologies Inc. (OTC: ACTX)

The QualityStocks Daily Newsletter would like to spotlight Advanced Container Technologies Inc. (OTC: ACTX).

Illinois Senators have voted in favor of a measure that would prevent law enforcement from usingcannabis smell as a probable cause for vehicle searches. SenatorRachel Ventura sponsored the measure, which advanced in a 33-to-20vote and is now headed to the Illinois House of Representatives forconsideration. Ventura said that her legislation was meant toprotect Illinoisians from unreasonable searches at traffic stops.She noted that law enforcement tends to pull over people of color “far too often” and that the odor of cannabis shouldn’t beprobable cause for these stops. Recreational cannabis is legal forboth residents and nonresidents in the state, and the plant’s“pungent scent” sticks to clothing for long after initialconsumption, she said. While the measure would keep police officersfrom searching vehicles due to the cannabis smell, it will not makeany changes to the state’s impaired driving policies, which bandriving while under the influence of cannabis. White peoplecomprised 88% of majority owners, 71% of minority owners, 90% ofthe board of directors and 80% of c-suite executives, while Latinoand Black people made up less than 10% of senior positions. Thismove to address another vestige of the prohibition era is likely tobe applauded by cannabis industry actors and other companies suchas Advanced Container Technologies Inc. (OTC: ACTX) because needless arrests will decrease.

Advanced Container Technologies Inc. (OTC: ACTX) is in the business of selling and distributing self-contained, automated, indoor “micro-farms” called Grow Pods, along with related equipment and supplies. Additionally, the company designs and sells patented proprietary medical-grade plastic containers, known as the Medtainer®, that store and grind pharmaceuticals, herbs, teas and other solids or liquids.

ACTX is the leading distributor of Grow Pods. With a controlled environment, food and herbs can be grown without pesticides, harmful chemicals or risk of pathogen contamination, and with low energy consumption. Restaurants, grocery stores, non-profits, MSOs and entrepreneurs can use Grow Pods to ensure a fresh supply of ultra-clean produce year-round.

The company entered the Grow Pod business in October 2020 with its acquisition of all shares of Advanced Container Technologies Inc., a California corporation. As of February 28, 2022, ACTX is exploring the acquisition of the assets and the assumption of some or all of the liabilities of GP Solutions Inc., the developer and manufacturer of Grow Pods, for which ACTX is currently the sole U.S. distributor.

Because Grow Pods can be located almost anywhere, produce can be grown closer to the point of consumption and harvested at its peak, providing nutritious fruits and vegetables where needed. Indoor micro-farms, utilizing a practice known as vertical farming, have attracted the attention of governments and universities, which are now promoting vertical farming as a way to combat food insecurity and inequities.

The United States Department of Agriculture (USDA) has stated that vertical farming “is no longer a futuristic concept.” The department is enthusiastic about vertical farming, particularly those utilizing repurposed shipping containers, such as Grow Pods. Arizona State University reports that vertical farming reduces water use by 90 percent compared to conventional farming but produces 10 times the crop yield.

Products

Grow Pods

One of the company’s main business units is focused on selling advanced, self-contained hydroponic containers called Grow Pods. These unique and innovative automated systems are essentially micro-farms that can be placed virtually anywhere and, with their controlled and specially filtered environment, allow cultivation of a wide variety of crops, 365 days a year. The Grow Pod controlled environment offers major advantages for the production of high-value crops. The ability to grow year-round and the ability to cultivate in a smaller footprint using less water and power are some of the primary advantages of the system. Grow Pods offer constant temperature, humidity and airflow control, as well as automated watering and lighting schedules for optimal growth and minimal labor requirements, regardless of crop.

Containers

ACTX meets the needs of the pharmaceutical and medical markets, including the cannabis and hemp industries, with patented packaging systems. The company designs, customizes, brands and sells proprietary medical grade plastic containers that can store pharmaceuticals, herbs, teas and other solids or liquids, with a special built-in feature that can grind solids and shred herbs. The company’s flagship container product is the patented Medtainer®, a child resistant, medical-grade herb container and grinder that is water-tight, air-tight and smell proof. Packaging in the cannabis industry is critical, with numerous stringent regulations about how cannabis products must be packaged and labeled. ACTX also offers custom-branded, compliant vacuum seal bags and other retail container solutions.

Equipment and Supplies

ACTX markets and sells two principal products: Grow Pods, which are specially modified insulated shipping containers manufactured by GP Solutions Inc., in which plants, herbs and spices may be grown hydroponically in a controlled environment, and Medtainers®, which may be used to store pharmaceuticals, herbs, teas and other solids or liquids and can grind solids and shred herbs. The company also markets and sells various products related to Grow Pods and the Medtainer®, as well as providing private labeling and branding services for purchasers of Medtainers® and certain related products.

GP Solutions manufactures and sells other products, such as humidity controllers and LED lighting systems for vertical farming. The company’s specially designed lighting panels are programmed to emit the exact wavelength of light that each crop requires. The system has a daybreak-to-nightfall feature that gives plants the proper chromatic signals to grow rapidly and fruitfully. High efficiency LED light strips supply the crops with a red and blue light spectrum required for photosynthesis in the spectrum that plants need most.

Market Overview

The global vertical farming market is expected to reach $33.02 billion by 2030, according to a new report by Grand View Research. The market is forecast to expand at a CAGR of 25.5 percent from 2022 to 2030, according to Grand View. Escalating production of biopharmaceutical products, including cannabis, is anticipated to drive the market. The building-based segment of the market is expected to register a significant CAGR of 27.8 percent over the projected period. In addition, the climate control segment is expected to see high growth.

The global cannabis packaging market is expected to reach $14.34 billion by 2028, according to analysis by Reports and Data. The analysis forecasts 1,700 percent growth in cannabis users by the end of 2026, with packaging likely observing a whopping 26.42 percent growth in the forecast period. There are significant barriers to entry in the cannabis packaging market, giving an advantage to companies already established in the sector. These barriers include developing a thorough knowledge of the myriad regulations that govern cannabis packaging (which differ in each state), and child-resistance requirements.

Management Team

Douglas P. Heldoorn is the Founder and Chairman of Advanced Container Technologies Inc. He also holds the positions of President, CEO and COO at the company. Mr. Heldoorn has served on the Board of Directors since its inception in 2013. He has also previously held the position of Executive General Manager at Nissan Motor Corp.

Jeffory A. Carlson is CFO and Treasurer of ACTX. Mr. Carlson has also served as the company’s Corporate Controller since 2014.

Advanced Container Technologies Inc. (OTC: ACTX), closed Monday's trading session at $0.3, even for the day, on 550 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.073/$1.25.

Recent News

Coyuchi Inc.

The QualityStocks Daily Newsletter would like to spotlight Coyuchi Inc.

  • Coyuchi’s line of gold-standard luxury home goods includesbedding, sheets, towels, apparel, and other home goods madeusing 100% organic cotton
  • The organic bedding market was valued at $836.4 million in2020, and is expected to grow at a CAGR of 5.1%, resulting in avalue of $1.1 billion by 2025
  • Coyuchi’s Bedroom Inspiration is uniquely designed to calm,revitalize, and build a mindfully made mood within an enduser’s personal organic sleeping space

At the forefront of consumer organic home products is Coyuchi, a gold standard in sustainable luxury home goods, includingbedding, sheets, towels, apparel, and other home items made using100% organic cotton. Bedding is one of the most personal suchitems, since we spend a significant portion of each day in closecontact with it. Conventional bedding is often made using processesthat require deep chemical treatments, and these treatments cancause the skin to feel itchy or cause other dermatologicalproblems. The rising awareness of conventional fiber treatmentmethods has caused an increase in demand for more natural,sustainable alternatives. Because of this, the organic beddingmarket is expected to rise at a CAGR of 5.1% to reach $1.1 billionby 2025, compared to $836.4 million in 2020 (https://ibn.fm/yCszf).

Coyuchi is the gold standard in sustainable luxury home goods. The company offers sustainably produced luxury organic bedding, sheets, towels, apparel, and other home goods for the environmentally conscious home. With a timeless, coastal-inspired aesthetic, Coyuchi uses only 100% organic cotton materials to manufacture all of its textiles.

The Company was built upon four foundational pillars: protect the planet, innovate circular design, live sustainably, and enrich the community. These guiding principles have proven an effective market strategy. In 2021, Coyuchi earned $33.3 million in net sales, amounting to 26% YoY growth (the industry average is only 5%). It also experienced 2x customer growth to 200,000 active customers, averaging a 35% customer repeat purchase rate.

With a seasoned leadership team, a robust e-commerce shopping experience, and a healthy customer base that drives the fast-growing organic luxury market, Coyuchi is prepared to propel a new phase of growth as the rest of the world finally awakens to sustainability at scale.

A Lucrative Market Ripe for the Taking

The global market for organic bedding, which was estimated at $814.3 million in 2020, is projected to reach $1.1 billion by 2027, growing at a CAGR of 4.9% over that period, according to Research and Markets. More specifically, the domestic organic bedding market is estimated at $240.1 million in 2020, according to Statista. Overall, the U.S. market for home textiles is currently valued at $25 billion annually, and, with a forecast annual growth rate of 5%, it is expected to reach $30 billion by the end of 2025.

Grand View Research reported in 2020 that shifting consumer preference toward high-end lifestyle products is a key factor driving the growth of the organic bedding market. Seventy-four percent of consumers are willing to pay more for sustainable products – a consumer preference that has steadily increased over the last few decades. Millennials especially favor ethical consumption over price when purchasing goods and services, with 83% of millennials reporting that they want the brands they purchase from to align with their beliefs and values (https://ibn.fm/PANNV). With a majority millennial customer base, Coyuchi is poised to capitalize on this trend.

Industry Defining Sustainability Practices

For 30 years, Coyuchi has explored organic farming and sustainable textiles and guarantees the highest environmental and ethical standards through a number of certifications such as The Global Organic Textile Standard (GOTS), Fair Trade Certified, and MADE SAFE®.

Coyuchi continues to push the organic textile market forward through its circularity initiatives and by supporting cross-industry sustainability advocates. Coyuchi’s mission to bring beauty and comfort to every home without sacrificing the health of our planet has resulted in a number of important sustainability checks and balances.

  • A Circular Business Model: Coyuchi has cultivated a holistic 360-degree approach that contributes to the fight against climate change with its take back and recycling program, 2nd Home™. In 2017, it became the first luxury home brand to implement such an initiative, and, since then, the company has eliminated 68,758 lbs. of toxic chemicals from homes and renewed 6,000 lbs. of textiles.
  • The Coyuchi Climate Council: In early 2022, Coyuchi introduced a cross-disciplinary council with a goal of Net Zero Emissions by 2025 and Net Positive Emissions by 2030. The Coyuchi Climate Council brings together influential minds across fashion, regenerative farming, and sustainability who have the knowledge and experience necessary to achieve climate change.
  • C4: The California Cotton & Climate Coalition: Most recently, Coyuchi announced it is a founding member of C4, which includes innovative, sustainable fashion, apparel, and personal care brands like MATE the Label, Outerknown, Reformation, and Trace. Working together pre-competitively, C4 creates a structure for investing in regionally grown, Climate Beneficial™ cotton and directly supports the livelihoods of the farmers that grew it. Coyuchi is the only home industry brand currently involved in the project.

Omnichannel Business Model

Coyuchi differentiates itself through an omnichannel and circular business model, both of which have proven a clear draw for customers. It was an early adopter of an e-commerce sales and marketing approach (over 80% of its sales are directly through coyuchi.com), creating a distinct advantage over incumbents and start-up newcomers in the luxury space. This has resulted in a high lifetime value customer, luxury retail partners such as Nordstrom, and a flagship store in Marin County.

Coyuchi’s Organic Textile Products

Coyuchi’s product assortment consists of consciously designed bedding, bath, apparel, and lifestyle products spread across about 1,400 SKUs. The company believes that its product assortment, produced from 100% organic cotton with Global Organic Textile Standard (GOTS) certification, provides it with a significant competitive advantage. GOTS is the world’s leading textile processing standard for organic fibers, ensuring the organic status of textiles after harvesting raw materials through environmentally and socially responsible manufacturing all the way to labeling, a major environmental and social benefit over conventional cotton product production.

Coyuchi’s focused product assortment consists of four core categories:

  • Bedding – A full suite of sustainable, organic, and high-quality sheets, duvet covers, blankets, and throws.
  • Bath – A luxurious line of towels, bath rugs, and mats.
  • Apparel – Premium apparel for men and women, including robes, sweaters, pants, and pajamas.
  • Lifestyle – The lifestyle category offers 135 SKUs, from organic napkins to crossbody totes.

Management Team

Eileen Mockus is President and CEO at Coyuchi. She has more than 25 years of experience in retail, having held positions in textile development at Patagonia, Pottery Barn Teen, and The North Face. She earned a bachelor’s degree in textiles and clothing from UC Davis and an MSBA from San Francisco State University.
Sejal Solanki is Chief Marketing Officer at Coyuchi. She previously served as the company’s Vice President of E-Commerce. Before joining Coyuchi, she worked at teen clothing giant Charlotte Russe. She oversees the company’s digital marketing, site experience, brand marketing, and e-commerce strategy.

Marcus Chung is Coyuchi’s COO, overseeing supply chain, sourcing strategy, sustainability, and IT. He previously held positions at notable direct-to-consumer brands Third Love and Stitch Fix, as well as national retailer The Children’s Place. He holds a bachelor’s degree from Wesleyan University and an MBA from UC Berkeley’s Haas School of Business.

Margot Lyons is Director of Sustainability and Sourcing at Coyuchi, where she works with strategic partners to ensure all the company’s product sustainability standards are met. She received a master’s degree in textiles and clothing from UC Davis.

Use of Proceeds

This round of funding will be used to increase Coyuchi’s enterprise value through expanded marketing, product category expansion, continued physical presence, and B2B strategic partnerships with wholesalers, and online marketplaces.

Recent News

chart

Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF)

The QualityStocks Daily Newsletter would like to spotlight Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF).

Arizona Metals (TSX: AMC) (OTCQX: AZMCF), a mineral exploration company engaged in advancing precious andbase metal deposits, chose potential historical high-grade copperdeposits in Arizona, a stable jurisdiction with a long history ofmining copper. “In the Fraser Institute’s annual survey, Arizonaand Nevada persistently score among the world’s most attractivemining jurisdictions due to the efficient permitting process andthe faster timeline for drilling and development, which helpdecrease the projects’ risks and reduce exploration costs. MarcPais, the president and CEO of Arizona Metals Corp., claims thatthe rapid deployment of drills is another feature of the project’sland ownership advantages, revealing that the company has averagedthree months turnaround for drilling permits. For comparison, otherjunior mining competitors often wait much longer, sometimes evenyears. The project is said to have already been attractingsignificant market attention. Still, the experienced managementteam expects to catch the eye of the mid-tier base and preciousmetal producers as the drill results are revealed during theexploration program,” a recent article reads. “We’re not minebuilders, but we know what the gold and copper companies arelooking for,” Paul Reid, the company’s executive chairman, isquoted as saying. “We’re in a jurisdiction they like, but we needto build a production profile that moves the needle for producerslooking for additional copper and gold production. We just need tokeep showing how big the Kay Mine Project can be while we continueto de-risk it.”

To view the full article, visit https://ibn.fm/N14q0

Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF) is a mineral exploration company engaged in advancing precious and base metal deposits in the state of Arizona. Its flagship copper-gold-zinc-silver asset is the Kay Mine Project, located in Yavapai County. The company also owns Sugarloaf Peak gold project in La Paz County.

The company in October 2022 received permit approval from the Bureau of Land Management (BLM) for two new drill pads, located approximately 1,200 meters west of the Kay Mine Deposit. These new pads will allow for testing of the company’s Western Target, while also allowing for drilling of additional coincident anomalies located between the Central and Western Targets. Construction of the drill road for the Central Target (located 500 meters west of the Kay Mine Deposit) is currently underway, with drilling expected to begin in November 2022. Road construction for the Western Target will begin upon confirmation of BLM acceptance of the company’s posted bond, with drilling expected to commence in Q1 2023.

The company is fully funded, with $60 million in cash as of June 30, 2022, to complete the remaining 18,000 meters planned for the Phase 2 program at Kay, as well as an additional 76,000 meters in the Phase 3 program (budgeted at $27 million), which will be used to test the numerous parallel targets heading west of the Kay Deposit, as well as the northern and southern extensions of the Kay Deposit.

Arizona Metals Corp. is based in Toronto, Canada.

Projects

Arizona Metals Corp. owns 100% of the Kay Mine property in Yavapai County, which is located on a combination of patented and BLM claims totaling 1,300 acres that are not subject to any royalties. An historic estimate by Exxon Minerals in 1982 reported a “proven and probable reserve of 6.4 million short tons at a grade of 2.2% copper, 2.8 grams per ton gold, 3.03% zinc, and 55 grams per ton silver.” The historic estimate has not been verified as a current mineral resource. None of the key assumptions, parameters, and methods used to prepare the historic estimate were reported by Exxon, and no resource categories were used. Significant data compilation, re-drilling and data verification may be required by a “qualified person” (as defined in National Instrument 43-101 – Standards of Disclosure for Mineral Projects) before the historic estimate can be verified and upgraded to be a current mineral resource. A qualified person has not done sufficient work to classify it as a current mineral resource, and Arizona Metals is not treating the historic estimate as a current mineral resource.

The company also owns 100% of the Sugarloaf Peak Property in La Paz County, which is located on 4,400 acres of BLM claims. Sugarloaf is a heap-leach, open-pit target and has a historic estimate of “100 million tons containing 1.5 million ounces (of) gold” at a grade of 0.5 grams per ton. The historic estimate at the Sugarloaf Peak Property was reported by Westworld Resources in 1983. The historic estimate has not been verified as a current mineral resource. None of the key assumptions, parameters, and methods used to prepare the historic estimate were reported, and no resource categories were used. Significant data compilation, re-drilling and data verification may be required by a qualified person before the historic estimate can be verified and upgraded to a current mineral resource. A qualified person has not done sufficient work to classify it as a current mineral resource, and Arizona Metals is not treating the historic estimate as a current mineral resource.

Market Opportunity

The World Gold Council, an industry association representing gold producers with hundreds of mining operations in nearly 50 countries around the world, reports that global demand for gold during the first six months of 2022 was 2,189 tons, a 12% increase in demand over the same period in 2021. Demand came primarily from gold bar and coin investors, jewelry consumers, central bank purchases to bolster currency reserves and technology manufacturing.

The average price per ounce for the period was $1,871, marking a 1% year-over-year increase. The council reported gold mine production for the period was up 3% over 2021 at 1,764 tons. For the remainder of 2022 and into 2023, the council projects flat gold demand with possible slight increases in gold mine production. The council notes that unpredictable geopolitical factors, the Ukraine war for example, and likelihood of global economic slowdown could have significant near-term impact on gold demand and prices.

Management Team

Marc Pais is President and CEO of Arizona Metals. He previously founded and served as President of Telegraph Gold (listed as Castle Mountain Mining), which was acquired by Equinox Gold, a TSX-listed mining company. He has seven years of experience as a Mining Analyst, with a focus on precious metals development companies. He holds a B.Sc. in Geological Engineering (Mineral Exploration) from Queen’s University in Canada.

David Smith is the Vice President, Exploration of Arizona Metals. He has 30 years of global precious metals exploration experience, including codiscovery of the Solidaridad/La Sabila deposit in Mexico with deposits estimated at 1 million ounces of gold. His core areas of expertise are managing mineral projects from acquisition to exploration, resource modeling and mineral project development. He holds an M.Sc. from the University of Oregon and an MBA from Pinchot University/Presidio Graduate School.

Paul Reid is the Executive Chairman of Arizona Metals. He previously founded and served as Executive Chairman of Telegraph Gold (listed as Castle Mountain Mining), which was acquired by Equinox Gold, a TSX-listed mining company. Paul has extensive experience as an Investment Banking professional, involved in raising capital, go-public transactions, and advisory services.

Vision Energy Corp. (OTCQX: AZMCF), closed Monday's trading session at $2.98, off by 2.9316%, on 149,937 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $2.30/$5.51.

Recent News

Lexaria Bioscience Corp. (NASDAQ: LEXX)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (NASDAQ: LEXX).

DehydraTECH(TM)-enabled drugs and product formats improve the speedof onset, increase bioavailability, increase brain absorption,enhance drug potency, reduce drug administration costs, and maskunwanted tastes, shown effective with a growing number of medicalapplications

Current DehydraTECH studies (animal and human) includehypertension, dementia, oral nicotine, epilepsy, and diabetes

Most recently, Lexaria’s DehydraTECH-CBD studies for hypertensionhave produced positive results, and the company is seeking INDstatus with the FDA

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has developed adisruptive drug delivery technology with multiple opportunities forsuccess in cannabinoids, oral nicotine and other activepharmaceutical ingredients (“APIs”). Lexaria’s patentedDehydraTECH(TM) technology is a formulation and dehydrationprocessing procedure that changes how the body detects and absorbsdrugs. The company currently has 28 granted patents, with many morepending patents in countries worldwide.

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator in drug delivery platforms. The company’s patented technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules. DehydraTECH promotes fast-acting, less expensive and more effective oral drug delivery and has been thoroughly evaluated through in vivo, in vitro and human clinical testing.

DehydraTECH is covered by 21 issued and more than 50 pending patents in over 40 countries around the world. Lexaria’s first patent was issued by the U.S. Patent and Trademark Office in October 2016 (US 9,474,725 B1), providing 20 years of patent protection expiring June 2034. Multiple patents have been awarded since then and are expected in the future.

Lexaria has a collaborative research agreement with the National Research Council (NRC), the Canadian government’s premier research and technology organization. The company has filed for patent protection for specific delivery of nicotine, vitamins, NSAIDs, testosterone, estrogen, cannabinoids, terpenes, PDE5 inhibitors (with brand names like Viagra), tobacco and more.

Lexaria began developing DehydraTECH in 2014 and has since continued to strengthen and broaden the technology. The company has no plans to create or sell Lexaria-branded products containing controlled substances. Instead, Lexaria licenses its technology to other companies around the world to offer consumers the best possible performance across an array of ingestible product formats.

The company’s technology is best thought of as an additional layer that providers of consumer supplements, prescription and non-prescription drugs, nicotine and CBD products can utilize to improve the effectiveness of their own existing or planned new offerings. Lexaria has licensed DehydraTECH to multiple companies, including a world-leading tobacco producer for the research and development of smokeless, oral-based nicotine products, and for use in industries that produce cannabinoid beverages, edibles and oral products.

DehydraTECH is suitable for use with a wide range of product formats including pharmaceuticals, nutraceuticals, consumer packaged goods and over-the-counter capsules, pills, tablets and oral suspensions.

DehydraTECH Technology

Lexaria’s DehydraTECH is designed specifically for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. DehydraTECH increases their effectiveness and improves the way active pharmaceutical ingredients enter the bloodstream. The major benefits to a subject ingesting a DehydraTECH-enabled drug or consumer product can be summarized by the following:

  • Speeds up delivery – the effects of the product are felt by the subject in just minutes.
  • Increases bioavailability – the technology is much more effective at delivering a drug or product into the bloodstream.
  • Increases brain absorption – animal testing suggests significant improvement in the quantity of drug delivered across the blood-brain barrier.
  • Improves drug potency – more of the ingested product is made available to the body, so lower doses are required to achieve the desired effect.
  • Reduces drug administration cost – lower doses mean lower overall drug costs.
  • Masks unwanted taste – the technology eliminates or reduces the need for sweeteners.

Lexaria has demonstrated in animal studies a propensity for DehydraTECH technology to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,900 percent, initiating additional new patent applications and opening possibilities for improved drug delivery.

Since 2016, DehydraTECH has repeatedly demonstrated, with cannabinoids and nicotine, the ability to increase bio-absorption by up to five to 10 times, reduce time of onset from one to two hours to just minutes, and mask unwanted tastes. The technology is to be further evaluated for additional orally administered bioactive molecules, including antivirals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) and nicotine.

Market Outlook

Lexaria’s ongoing research and development efforts are mainly focused on development of product candidates across several key segments:

  • Oral Cannabinoids – a market estimated to be worth $18.4 billion in 2021 and expected to reach $46.2 billion by 2025.
  • Antivirals – an estimated $52.1 billion market in 2021 that’s expected to grow to $66.7 billion by 2025.
  • Oral Mucosal Nicotine – smokeless tobacco products, a $13.6 billion market in 2018, is forecast to grow at 7.2 percent annually through 2025.
  • Human Hormones – estrogen and testosterone replacement therapies represented a $21.9 billion market in 2019, with a forecast CAGR of 7.7 percent through 2027.
  • Ibuprofen and Naproxen – NSAID sales totaled $15.6 billion globally in 2019 and are projected to reach $24.4 billion by 2027.
  • Vitamin D3 – the global market size was $1.1 billion in 2021, growing at 7 percent per year and expected to reach $1.7 billion in 2026.

Management Team

Chris Bunka is Chairman and CEO of Lexaria Bioscience Corp. He is a serial entrepreneur who has been involved in several private and public companies since the late 1980s. He has extensive experience in the capital markets, corporate governance, mergers and acquisitions, as well as corporate finance. He is named as an inventor on multiple patent innovations.

John Docherty, M.Sc., is the President of Lexaria. He is a pharmacologist and toxicologist, and a specialist in the development of drug delivery technologies. He is the former president and COO of Helix BioPharma Corp. (TSX: HBP). He is named as an inventor on multiple issued and pending patents.

Greg Downey is Lexaria’s CFO. He has more than 35 years of diverse financial experience in the mining, oil and gas, manufacturing, and construction industries, and in the public sector. He served for eight years as CFO for several public companies and has provided business advisory and financial accounting services to many large organizations.

Gregg Smith is a strategic advisor to Lexaria. He is a founder and private investor with Evolution VC Partners. He is a member of the Sand Hill Angels and held previous investment banking roles with Cowen and Company and Bank of America Merrill Lynch.

Dr. Philip Ainslie serves as a scientific and medical advisor to Lexaria. He is co-director for the Centre for Heart, Lung and Vascular Health, Canada. He is also Research Chair in Cerebrovascular Physiology and Professor at the School of Health and Exercise Sciences, Faculty of Health and Social Development at the University of British Columbia.

Lexaria Bioscience Corp. (LEXX), closed Monday's trading session at $2.35, off by 0.843882%, on 11,067 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $1.80/$4.83.

Recent News

CNS Pharmaceuticals Inc. (NASDAQ: CNSP)

The QualityStocks Daily Newsletter would like to spotlight CNS Pharmaceuticals Inc. (NASDAQ: CNSP).

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development ofnovel treatments for primary and metastatic cancers in the brainand central nervous system, today announced that more than 100patients have been enrolled in the company’s potentially pivotalstudy with its lead product candidate, Berubicin. “We have longpromised a study with a robust sample size sufficient toeffectively determine Berubicin’s therapeutic potential,” said JohnClimaco, CEO of CNS Pharmaceuticals. “Today’s achievement shows weare doing just that. Enrolling over 100 patients in this relativelyrare disease in a little more than 18 months is a remarkableachievement, which speaks to the unmet clinical need in GBM and theexcitement about Berubicin in the neuro-oncology clinical communityworldwide. For investors, we have said repeatedly we create valueby moving Berubicin rapidly toward a potential approval and patientenrollment is the cornerstone of that goal. Lastly, having 100patients in our study in Q2 2023 puts our interim analysis ontarget for Q3.”

To view the full press release, visit https://ibn.fm/xOMHO

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system.

The company was founded in 2017 and is headquartered in Houston, Texas.

Organ Targeted Therapeutics

The company’s lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Berubicin also has potential to treat other central nervous system malignancies. Based on limited clinical data, Berubicin appears to be the first anthracycline to cross the blood brain barrier in the adult brain, and it was the subject of a successful Phase 1 study which found the MDT and produced efficacy data as well.

CNS holds a worldwide exclusive license to the Berubicin chemical compound. The company has acquired all requisite data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase I clinical trial of Berubicin in malignant brain tumors. In this trial, 44% of patients experienced a statistically significant improvement in clinical benefit. In 2017, CNS entered into a collaboration and asset purchase agreement with Reata.

CNS intends to explore the potential of Berubicin to treat other diseases, including pancreatic and ovarian cancers and lymphoma. The company is also examining plans to develop combination therapies that include Berubicin.

CNS estimates that more than $25 million in private capital and grants were invested in Berubicin prior to the company’s $9.8 million IPO in November 2019.

CNS intends to submit an IND for Berubicin during the fourth quarter of 2020 and expects to commence a Phase II clinical trial of Berubicin for the treatment of GBM in the U.S. in Q1 2021. A sub-licensee partner was awarded a $6 million EU/Polish National Center for Research and Development grant to undertake a Phase II trial of Berubicin in adults and a first-ever Phase I trial in pediatric GBM patients in Poland in 2021.

The company’s second drug candidate, WP1244, is a novel DNA binding agent licensed from the MD Anderson Cancer Center. In preclinical studies, WP1244 proved to be 500-times more potent than the chemotherapeutic agent, daunorubicin, in inhibiting tumor cell proliferation. The company has entered into a sponsored research agreement with the MD Anderson Cancer Center to further the development of WP1244.

CNS Pharmaceuticals recently engaged U.S.-based Pharmaceutics International Inc. and Italian BSP Pharmaceuticals SpA for the production of the Berubicin drug product. The company has implemented a dual-track manufacturing strategy to mitigate COVID-19-related risks, diversify its supply chain and provide for localized availability of Berubicin. CNS has already completed synthesis of Berubicin’s active pharmaceutical ingredient (API) and has shipped the API to both manufacturers in order to prepare an injectable form of Berubicin for clinical use.

Global Brain Tumor Therapeutics Market

The high recurrence rate of malignant brain tumors is due to reappearance of focal masses, indicating that a sub-population of tumor cells in these cancers may be insensitive to current therapies and may be responsible for reinitiating tumor growth. This necessitates the development of newer drugs in the market that demonstrate greater efficacy in treating such aggressive cancers.

A global increase in neurological disorders has placed increased attention on cancers of the brain over the past decade. Neurological disorders are becoming one of the most prevalent types of disorders, due to longer life expectancy, greater exposure to infection and an increasingly sedentary lifestyle. Because few treatments for primary and metastatic cancers of the brain exist, costs are high and have acted as a restraint for the brain tumor therapeutics market.

Despite progress in surgery, radiotherapy and chemotherapeutic strategies, effective treatments for brain cancer are limited by a lack of specific therapies for the brain and the difficulty in transporting therapeutic compounds across the blood brain barrier. Therefore, there is a significant need for novel and effective therapeutic drugs and strategies that prolong survival and improve quality of life for brain tumor patients.

Several companies are making significant investments into R&D, which is expected to bring more treatment options to the market in the near future. Industry reports consistently project continued growth in the market.

One report estimates that the global brain tumor therapeutics market will reach a valuation of $2.74 billion in 2023, with the market expected to register a CAGR of 11% during the forecast period from 2018 to 2023. Another report projects that the global brain tumor therapeutics market will reach $3.4 billion by 2025, up from $2.25 billion in 2019 (http://nnw.fm/eDUjp).

Management Team

John M. Climaco is the CEO of CNS Pharmaceuticals. For 15 years, Climaco has served in leadership roles for a variety of health care companies. Recently, Climaco served as the Executive Vice President of Perma-Fix Medical S.A, where he managed the development of a novel method to produce Technitium-99. Climaco also served as President and CEO of Axial Biotech Inc., a DNA diagnostics company. In the process of taking Axial from inception to product development to commercialization, Climaco forged strategic partnerships with Medtronic, Johnson & Johnson and Smith & Nephew.

Christopher Downs, CPA, is the company’s Chief Financial Officer. Downs previously served as Interim Chief Financial Officer and Executive Vice President of InfuSystem Holdings Inc. (NYSE: INFU), a supplier of infusion services to oncologists in the United States. Downs holds a Bachelor of Science from the United States Military Academy at West Point, an MBA from Columbia Business School and a Master of Science in Accounting from the University of Houston-Clear Lake.

Dr. Donald Picker is the Chief Scientific Officer of CNS. Picker has over 35 years of drug development experience. Prior to joining CNS, Picker worked at Johnson Matthey, where he was responsible for the development of Carboplatin, one of the world’s leading cancer drugs, which was acquired by Bristol-Myers Squibb with annual sales of over $500 million. In addition, he oversaw the development of Satraplatin and Picoplatin, third-generation platinum drugs currently in late-stage clinical development.

Sandra L. Silberman, M.D., Ph.D., is the Chief Medical Officer of CNS Pharmaceuticals. Silberman is a hematologist/oncologist who earned her B.A., Sc.M. and Ph.D. from the Johns Hopkins University School of Arts and Sciences, School of Public Health and School of Medicine, respectively, and her M.D. from Cornell University Medical College. She then completed both a clinical fellowship in hematology/oncology and a research fellowship in tumor immunology at the Brigham & Women’s Hospital and the Dana Farber Cancer Institute in Boston, Massachusetts. Silberman has played key roles in the development of many drugs, including Gleevec(TM), for which she led the global clinical development at Novartis. Silberman advanced several original, proprietary compounds into Phases I through III during her work with leading biopharmaceutical companies, including Bristol-Myers Squibb, AstraZeneca, Imclone and Roche.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP), closed Monday's trading session at $0.7492, off by 0.119984%, on 942,307 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.6105/$13.20.

Recent News

SideChannel Inc. (OTCQB: SDCH)

The QualityStocks Daily Newsletter would like to spotlight SideChannel Inc. (OTCQB: SDCH).

Massachusetts-headquartered cybersecurity services and technologyprovider SideChannel Inc. has dedicated itself to serving SMBcompanies who may be unable to employ on-staff cyber riskmanagement personnel, delivering expertise on contract instead

SideChannel recently bolstered its “virtual” chief informationsecurity officer (“vCISO”) service by partnering with automatedsupply chain risk management platform developer Darkbeam, aLondon-based company similarly focused on client cyber security

Darkbeam’s platform provides tools for clients to do data dives onaffiliated domains and monitor changes in their security status byanalyzing a “Cyber Intelligence Quotient”

SideChannel also offers clients a microsegmentation tool as asoftware-as-a-service (“SaaS”) subscription product, which thecompany also can operate as a managed service if clients prefer

Businesses have enough challenges managing their potentialvulnerability to cyber attacks dwithout having to worry about thecyber risk of other companies involved in their supply chain aswell.

Cybersecurity services and technology provider SideChannel (OTCQB: SDCH) announced recently that it is partnering its virtual chiefinformation security officer (“vCISO”) expertise with London-basedcyber intelligence provider Darkbeam’s advanced risk managementplatform to grant clients greater tools for preventing losses dueto attacks on their computer data infrastructure — both internallyand across the breadth of their supply chains.

SideChannel Inc. (OTCQB: SDCH) simplifies cybersecurity for mid-market companies by matching them with highly experienced information security officers at a cost lower than building an in-house information security team or hiring a full-time CISO.

SideChannel’s team of virtual Chief Information Security Officers (vCISOs) possesses a combined 400-plus years of experience in cybersecurity. They’ve honed their skills and abilities in places like Anthem, Dick’s Sporting Goods, Best Buy, TD Bank and the Pentagon. SideChannel lends this talent to clients, creating value in the form of a bespoke cybersecurity program perfectly sized for the growing enterprise.

SideChannel is committed to creating top-tier cybersecurity programs for SMBs to help them protect their data and assets. To date, SideChannel has created more than 50 multi-layered cybersecurity programs for its clients.

 

Reports show that cyberattacks on SMBs have increased in recent years, as organizations’ network attack surfaces have grown exponentially with remote and in-office workers increasingly relying on cloud environments, mobile devices, software applications and third-party suppliers to conduct business.

SideChannel continues expanding its service offerings, workforce and customer base, attracting over 20 virtual CISOs to serve across industries including fintech, biotech, healthcare, manufacturing, legal, defense and technology services. The company is based in Worcester, Massachusetts.

Market Opportunity

An analysis from ReportLinker states that the global cybersecurity market is expected to grow from an estimated value of $173.5 billion in 2022 to $266.2 billion by 2027, recording a CAGR of 8.9% for the period.

The increased number of data breaches worldwide, the ability of malicious actors to operate from anywhere in the world, the links between cyberspace and physical systems, and the difficulty of reducing vulnerabilities and consequences in complex cyber networks are some factors driving cyber security market growth, according to the report.

A lack of cybersecurity professionals and the budget constraints among SMBs and start-ups in developing economies are expected to hinder market growth. Cybercriminals are using automated techniques to attack SMBs’ networks to take advantage of their weak security infrastructures. To save money, time and resources, SMBs are seeking cybersecurity solutions.

Enclave

Enclave expands upon SideChannel’s cybersecurity service offerings by solving a pervasive network security problem with a simple tool.

A comprehensive cloud and network security solution, Enclave enables IT teams to contain breaches faster, reduce network outages, minimize latency and strengthen overall security defense.

Enclave creates the foundation for a Zero Trust network security model IT can build upon.

With Enclave, IT can easily segment their company’s network, organize personnel and computing devices at the employee workload level, and implement security controls across all network segments.

Enclave was designed and purpose built to serve the growing security needs of SMBs, a traditionally underserved market that is more prone to cyberattacks but has limited protection due to smaller budgets, inadequate IT security staffing and a lack of cybersecurity awareness among top executives.

Enclave is an affordable and effective network security solution that shrinks the attack surface area exposed to a cyber intruder and significantly reduces the amount of effort required to operate securely.

Management Team

Brian Haugli is CEO of SideChannel. He has led programs for the U.S. Department of Defense, the Pentagon, and Fortune 500 companies. He is an expert on National Institute of Standards and Technology guidance, threat intelligence implementations and strategic organizational initiatives. He is a professor at Boston College, Woods College of Advancing Studies Master’s Program in Cybersecurity. He is also a contributing author for the Wiley book ‘Cybersecurity Risk Management’.

Ryan Polk is CFO at SideChannel. He has been the principal of Perissos Partners, an executive consulting firm, since June 2017. He also served in executive roles in the portfolio companies owned by Lacy Diversified, with combined revenue approaching $2 billion. He served as the Vice President for Corporate Financial Planning and Analysis for Brightpoint, a publicly traded, Fortune 500 mobile device logistics company. He earned a bachelor’s degree in accounting and industrial management from Purdue University.

Nicholas Hnatiw is Chief Technology Officer at SideChannel. Prior to joining the company, he served as the technical director for network operations supporting U.S. Cyber Command, U.S. Intelligence Agencies and other Department of Defense research organizations. He was also the CEO of Loki Labs, a cyber security firm. He earned a bachelor’s degree in computer engineering and computer science at the University of Massachusetts, Amherst.

Bill Roberts is SideChannel’s CISO. He most recently served as the vice president, IS & CISO for Hologic Inc., a global medical device company, where he established cyber security and IT compliance programs. Prior to Hologic, he was vice president of information security for Cytyc Corporation, which was acquired by Hologic in 2007. At Cytyc, he managed global IT as the company grew from 140 employees to 1,500 and from $40 million in revenue to over $750 million.

SideChannel Inc. (OTCQB: SDCH), closed Monday's trading session at $0.06666, off by 4.7714%, on 3,610 volume. The average volume for the last 3 months is 3,610 and the stock's 52-week low/high is $0.0412/$0.18.

Recent News

Fintech Ecosystem Development Corp. (NASDAQ: FEXD)

The QualityStocks Daily Newsletter would like to spotlight Progressive Care Inc. (OTCQB: FEXD).

Fintech Ecosystem Development Corp. (NASDAQ: FEXD) is a special purpose acquisition company (SPAC) formed for the purpose of effecting one or more business combinations with an intent to focus on the financial technology sector.

The company’s mission is to create and grow a global financial services ecosystem to address unmet mobile money needs in developing and industrialized countries and markets. FEXD plans to achieve this by acquiring and merging with financial technology pioneers that have the potential to help establish its global fintech ecosystem, and by continuing the development of proprietary technologies and applications to keep the company at the forefront of the cashless society market.

Digital money is replacing physical cash. Consumers can buy products and services from anywhere in the world and make payments across borders. Parents can send money to students studying in other countries. Migrant workers are sending money to families in developing nations. Rural villagers without banks can send and receive money using their smartphones. FEXD is developing mobile transaction platforms, applications and services that are helping to implement these changes.

The company plans to offer a diverse portfolio of products and services to consumers and businesses in the United States, South Asia, East Asia, Africa, Europe and Latin America. Its growth strategy includes acquisition, innovation and market development.

FEXD is a Delaware corporation based in Collegeville, Pennsylvania. The company was launched in May 2021 by a management team led by Dr. Saiful Khandaker that has extensive experience in developing and managing financial service platforms and applications, primarily in the mobile money sector. FEXD is sponsored by Revofast LLC.

Acquisition Targets

In September 2022, FEXD announced definitive agreements for business combinations with Rana Financial Inc., a Georgia corporation, and Mobitech International LLC (dba Afinoz), a limited liability company organized in the United Arab Emirates. The agreements call for Rana and Afinoz to become wholly owned subsidiaries of FEXD, with the combined company expected to continue trading on the Nasdaq under existing ticker symbol ‘FEXD’. The mergers are expected to close in Q2 2023.

Rana Financial

Rana Financial is a licensed money transfer company founded in 2009. Rana provides fast and affordable online and mobile transfer of funds between the U.S. and Latin America. Rana has been providing money transfer services in the U.S. market for 13 years and has 30,000 active users. Rana’s money transfer business grew to 200,000 transactions in 2021. The merger agreement values Rana at an implied $78 million enterprise value.

Mobitech International LLC

Mobitech International LLC (dba Afinoz) is an artificial intelligence-enabled digital lending platform used by India’s leading banks, non-banking financial companies and fintech loan providers. Afinoz’s fintech platform supports enterprises making loans primarily to middle- and working-class borrowers via its website or through its mobile phone application. Afinoz’s platform makes loans available and affordable to millions of Indian workers and unbanked users by providing access at a low cost. Afinoz’s platform has more than 50 lending partners, and its database of registered users in India includes more than two million individuals. The merger agreement values Afinoz at an implied $120 million enterprise value.

Market Opportunity

According to analysis by global market research firm Mordor Intelligence, the worldwide financial technology market is valued at approximately $194 billion in 2023 and is projected to grow to nearly $500 billion by 2028, representing a CAGR of 18.97% for the forecast period. According to the report, various financial crises and the COVID-19 pandemic have fueled consumer adoption of, and investor interest in, fintech over the past several years.

Management Team

Dr. Saiful Khandaker is Founder, CEO and President of FEXD. He is Group CEO and founder of FAMA Holdings Inc., a global developer of fintech platforms, applications and services based in the U.S. with offices in the U.K., India, Bangladesh and Zambia. He is currently leading the development of the FAMACASH™ network, a global fintech ecosystem to provide fast, affordable mobile money services in underserved countries such as Bangladesh. Before founding FAMA, Dr. Khandaker spent more than two decades leading the development of software solutions for Fortune 100 companies and startups. He also helped numerous clients modernize their fintech services as Chief Technology Officer at Mi3. He holds a Doctor of Management in Organizational Leadership, a Master of Science in Technology Management, and a Bachelor of Science in Computer Information Systems.

Jenny Junkeer is CFO at FEXD. She is a Chartered Accountant with over 17 years of experience. As CEO of Junkeer New Era Consulting, she leads a team specializing in helping companies launch and optimize business operations in fast-changing industries. She has extensive experience helping organizations scale operations to maximize value. She is an Adjunct Association Professor at Deakin University in Australia, a board member of the Global Health Initiative Foundation, and Director of Implementation at ConnectCV. She holds a Bachelor of Commerce Degree (Honors) from Monash University.

FingerMotion Inc. (FEXD), closed Monday's trading session at $10.6, up 0.283822%, on 301,342 volume. The average volume for the last 3 months is 301,342 and the stock's 52-week low/high is $9.96/$11.00.

Recent News

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF)

The QualityStocks Daily Newsletter would like to spotlight Progressive Care Inc. (CSE: RFLX) (OTCQB: RFLXF).

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) is a strategic minerals company focused on locating and developing economic properties in the strategic metals and advanced materials space. The company aims to improve domestic specialty mineral infrastructure efficiencies to meet surging national demand from North American manufacturers, effectively positioning itself as one of the only North American suppliers of high purity natural graphite for hi-tech applications.

Reflex Advanced Materials is based in Vancouver, British Columbia. Its project portfolio includes the Ruby Graphite Deposit in Montana and the ZigZag Lithium Property in Ontario.

Projects

Ruby Graphite Project

Located in a mining-friendly jurisdiction in southwest Montana, the Ruby Graphite Deposit is a low cost, rapid re-entry opportunity that produced roughly 2,400 tons of graphite from 1902 to 1948. Reflex Advanced Materials holds mining rights for 755 hectares at the Ruby Graphite Project, with 96 federal lode mining claims. Recent samples assay at 95.8% to 98.4% total carbon.

The site is notable as the only combined U.S. graphite flake and vein graphite source. Vein graphite is ideal for energy storage applications, because it requires fewer steps to achieve purity than synthetic alternatives and is therefore far less environmentally damaging. This is expected to play a key role in the project’s development as demand for electric vehicles continues to surge.

In March 2023, the company announced its submittal of permit applications to the Bureau of Land Management in respect of its exploration of the Ruby Graphite Project. Its initial drill program, expected to take place in the summer of 2023, includes plans for 3,500 total meters of drilling, cored to an average depth of 130 meters. The targets for this drill program have been identified using historical data from original mine operations and data gathered for the initial 43-101 technical report on the project, dated January 31, 2023.

ZigZag Lithium Property

Located in the Thunder Bay Mining Division of Ontario, the ZigZag Lithium Property consists of eight mining claims spanning roughly 2,710 hectares. Mineralization at the property, most notably lithium, is based in pegmatite dikes and concentrated in spodumene crystals, which are consistent throughout the entire unit.

Spodumene is readily observable in outcrops and in drill cores, with crystal sizes ranging from 3-15cm, on average.

Reflex Advanced Materials and American Energy Technologies Company Metallurgical Partnership

Reflex Advanced Materials has entered into a material processing agreement with American Energy Technologies Co., which is based in Arlington Heights, Illinois, to conduct metallurgical testwork with the goal of creating a technical support data package for Reflex’s target customer base, U.S. Federal agencies and qualification programs with hi-tech customers in the battery and battery storage business.

The resulting coated, spherionized, purified graphite (CSPG) material that is expected to be created from the aforementioned tests will be used to provide potential customers of CSPG with samples so that they can begin the material qualification process.

Market Opportunity

Graphite is an ideal battery anode and has dominated the market since the proliferation of lithium-ion batteries. Despite this demand, there is currently no significant production of lithium-ion battery anode material in North America.

Instead, most graphite sold in North America today is sourced from Chinese producers. U.S. President Joe Biden highlighted this sourcing disparity in a 2022 address:

“The United Stated depends on unreliable foreign sources for many of the strategic and critical materials necessary for the clean energy transition – such as lithium, nickel, cobalt, graphite and manganese for large-capacity batteries,” he said. “Demand for such materials is projected to increase exponentially as the world transitions to a clean energy economy.”

The U.S. Department of Energy is in the process of awarding $2.8 billion to expand domestic manufacturing of batteries for electric vehicles and combat this foreign dependency. Reflex Advanced Materials has identified its Ruby Graphite Project as a prime candidate for U.S.-sponsored initiatives due to the rarity and scarcity of natural graphite deposits in the country.

Processing graphite domestically in the U.S. is expected to provide Reflex Advanced Materials a competitive advantage as manufacturers begin to seek out American supply in the face of increased diplomatic tension. This is critical, as a rise in anode demand is expected to fuel a shortage of 8 million tonnes of graphite by 2040. World Bank Group projects 494% growth in total graphite demand by 2050.

Leadership Team

Paul Gorman is the CEO and a Director of Reflex Advanced Materials. He brings to the company over 25 years of experience in junior mining finance, public listings, viability assessment and operational rationalization. For 18 years, Mr. Gorman served as president and managing partner of Riverbank Capital, where he played an instrumental role in raising more than $85 million for small-cap companies. In 2008, he funded Industrial Minerals Inc. (later Northern Graphite) and served in an advisory role for four other graphite companies, contributing significantly to the revitalization of the junior graphite space in North America. Mr. Gorman founded Mega Graphite Inc. in 2009 and has served as chief executive for three other companies.

Tasheel Jeerh, CPA, is the company’s CFO. He is a finance and accounting professional with over a decade of experience spanning both public and private sectors. Prior to joining Reflex Advanced Materials, Mr. Jeerh played a pivotal role in the growth of a private upstream oil and gas firm, dealing with over $2 billion in M&A activity and $1 billion in financing activities. He gained his designation at PricewaterhouseCoopers, where he worked as a manager in the assurance practice.

Greg Bell is Project Manager for Reflex Advanced Materials. He is a multi-disciplined engineering management professional with more than 40 years of experience in the natural resources sector. Mr. Bell has successfully built and managed several start-up operations in various capacities. He has been active in graphite and lithium exploration for the past seven years.

Christopher W. Hill leads the company’s Corporate Development initiatives. He is an investor and entrepreneur with over a decade of experience in the capital markets. Mr. Hill began his career as an investment advisor and then began to consult and advise private companies on their paths to becoming publicly traded. He specializes in corporate development and strategic financing utilizing his large network in the capital markets.

Reflex Advanced Materials Corp. (RFLXF), closed Monday's trading session at $0.3015, off by 24.625%, on 3,500 volume. The average volume for the last 3 months is 3,500 and the stock's 52-week low/high is $0.25/$0.765.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.